Mirae Asset Global Investments Co., Ltd. Blueprint Medicines Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,291 shares of BPMC stock, worth $216,728. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,291

Previous 1,869 22.58%

Holding current value

$216,728

Previous $201,000 4.98%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$84.1 - $120.5 $35,490 - $50,851	422 Added 22.58%	2,291 $211,000
Q2 2024 Jul 30, 2024	SELL	$85.18 - $108.78 $2.78 Million - $3.55 Million	-32,663 Reduced 94.59%	1,869 $201,000
Q1 2024 May 01, 2024	SELL	$73.17 - $99.79 $210,875 - $287,594	-2,882 Reduced 7.7%	34,532 $3.28 Million
Q4 2023 Jan 24, 2024	BUY	$43.96 - $92.84 $6,374 - $13,461	145 Added 0.39%	37,414 $3.45 Million
Q3 2023 Oct 26, 2023	BUY	$46.9 - $66.0 $66,457 - $93,522	1,417 Added 3.95%	37,269 $1.87 Million
Q2 2023 Aug 10, 2023	SELL	$42.2 - $66.37 $62,287 - $97,962	-1,476 Reduced 3.95%	35,852 $2.27 Million
Q1 2023 May 04, 2023	BUY	$37.97 - $50.0 $269,207 - $354,500	7,090 Added 23.45%	37,328 $1.68 Million
Q4 2022 Feb 09, 2023	BUY	$41.06 - $66.48 $2,586 - $4,188	63 Added 0.21%	30,238 $1.32 Million
Q3 2022 Nov 10, 2022	BUY	$49.93 - $77.7 $446,124 - $694,249	8,935 Added 42.07%	30,175 $1.99 Million
Q2 2022 Jul 26, 2022	BUY	$45.23 - $70.15 $960,685 - $1.49 Million	21,240 New	21,240 $1.07 Million
Q4 2021 Feb 08, 2022	SELL	$94.25 - $115.99 $11.6 Million - $14.3 Million	-123,042 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $1.95 Million - $2.63 Million	24,058 Added 24.3%	123,042 $12.7 Million
Q2 2021 Aug 11, 2021	BUY	$82.78 - $101.0 $2.7 Million - $3.3 Million	32,635 Added 49.19%	98,984 $8.71 Million
Q1 2021 May 13, 2021	BUY	$90.71 - $108.28 $2.61 Million - $3.12 Million	28,826 Added 76.82%	66,349 $6.45 Million
Q4 2020 Feb 10, 2021	BUY	$92.08 - $124.48 $618,961 - $836,754	6,722 Added 21.82%	37,523 $4.21 Million
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $646,624 - $902,063	9,731 Added 46.18%	30,801 $2.86 Million
Q2 2020 Aug 11, 2020	BUY	$57.09 - $79.27 $510,384 - $708,673	8,940 Added 73.7%	21,070 $1.64 Million
Q1 2020 May 12, 2020	BUY	$48.11 - $82.22 $57,395 - $98,088	1,193 Added 10.91%	12,130 $710,000
Q4 2019 Feb 12, 2020	BUY	$66.73 - $82.59 $94,022 - $116,369	1,409 Added 14.79%	10,937 $876,000
Q3 2019 Nov 12, 2019	BUY	$72.9 - $101.41 $446,148 - $620,629	6,120 Added 179.58%	9,528 $700,000
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $250,624 - $333,302	3,408 New	3,408 $322,000

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Blueprint Medicines Corp Transaction History